Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
As of 17 November 2026, for the company name Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. as recorded, 11 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 39 records, across 22 drug names; since 21 August 2026, the records list Accepted: 3 applications, No longer listed under review: 3 applications; the chemical-drug catalogue lists 20 active records with this name as holder; 23 active API registrations list this name as first registered company; 11 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
39 acceptance records as first applicant, grouped into 22 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Dydrogesterone Tablets 1 records · Latest accepted 2026/10/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602566 | Generic | 2026/10/19 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
雌二醇地屈孕酮片 · No verified English name 1 records · Latest accepted 2026/10/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602510 | Generic | 2026/10/13 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Thymalfasin for Injection 1 records · Latest accepted 2026/09/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601718 | Supplement | 2026/09/10 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
司美格鲁肽注射液 · No verified English name 14 records · Latest accepted 2026/04/22
New drug · 14
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600057 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600056 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600055 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600054 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600053 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600052 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600051 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600050 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400713 | New drug | 2024/07/16 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400712 | New drug | 2024/07/16 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400686 | New drug | 2024/07/10 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400685 | New drug | 2024/07/10 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400684 | New drug | 2024/07/10 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400683 | New drug | 2024/07/10 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Clindamycin Palmitate Hydrochloride Granules 1 records · Latest accepted 2025/05/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501776 | Generic | 2025/05/15 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Roxadustat Capsules 2 records · Latest accepted 2025/04/23
Generic · 2
Glucosamine Sulfate Capsules 1 records · Latest accepted 2025/03/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501169 | Generic | 2025/03/25 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2025/02/07
Generic · 2
Amlodipine Besylate and Atorvastatin Calcium Tablets 1 records · Latest accepted 2025/01/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500227 | Supplement | 2025/01/27 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
依折麦布阿托伐他汀钙片(I) · No verified English name 1 records · Latest accepted 2024/11/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402030 | Supplement | 2024/11/30 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., Ltd | CDE ↗ |
Ezetimibe and Atorvastatin Calcium Tablets(II) 1 records · Latest accepted 2024/11/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402031 | Supplement | 2024/11/30 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., Ltd | CDE ↗ |
Atorvastatin Calcium Tablets 2 records · Latest accepted 2024/09/14
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401493 | Supplement | 2024/09/14 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Shandong Lukang Group Saite Co., Ltd. | CDE ↗ |
| CYHB2401492 | Supplement | 2024/09/14 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Shandong Lukang Group Saite Co., Ltd. | CDE ↗ |
Epalrestat Tablets 1 records · Latest accepted 2024/07/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401994 | Generic | 2024/07/03 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Agomelatine Tablets 1 records · Latest accepted 2024/07/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401993 | Generic | 2024/07/03 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Atosiban Acetate Injection 2 records · Latest accepted 2024/04/03
Generic · 2
磷酸奥司他韦干糖浆 · No verified English name 1 records · Latest accepted 2024/02/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400314 | Supplement | 2024/02/29 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., Ltd | CDE ↗ |
Fluvoxamine Maleate Tablets 1 records · Latest accepted 2024/02/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400595 | Generic | 2024/02/08 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Cetrorelix Acetate for Injection 1 records · Latest accepted 2024/02/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400431 | Generic | 2024/02/02 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2023/02/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300525 | Generic | 2023/02/15 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Tianjin Han Rui Pharma Co., Ltd. romanized | CDE ↗ |
复方匹可硫酸钠颗粒 · No verified English name 1 records · Latest accepted 2023/02/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300307 | Generic | 2023/02/02 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Olmesartan Medoxomil and Amlodipine Besylate Tablets 1 records · Latest accepted 2022/02/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200352 | Generic | 2022/02/21 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Bivalirudin for Injection 1 records · Latest accepted 2021/09/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101681 | Generic | 2021/09/03 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
6 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 3 applicationsNo longer listed under review: 3 applications
- 2026/11/14No longer listed under review
Roxadustat Capsules
CYHS2501521
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2025/04/23
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/14No longer listed under review
Roxadustat Capsules
CYHS2501520
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2025/04/23
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/13No longer listed under review
Dydrogesterone Tablets
CYHS2602566
Fact date: 2026/11/13 · Date added to this site: 2026/11/13
Accepted: 2026/10/19
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/19Accepted
Dydrogesterone Tablets
CYHS2602566
Fact date: 2026/10/19 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/13Accepted
雌二醇地屈孕酮片 · No verified English name
CYHS2602510
Fact date: 2026/10/13 · Date added to this site: 2026/10/21
View source ↗ - 2026/09/10Accepted
Thymalfasin for Injection
CYHB2601718
Fact date: 2026/09/10 · Date added to this site: 2026/10/21
View source ↗
Under review
11 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 雌二醇地屈孕酮片 · No verified English name | CYHS2602510 | Generic | 2026/10/13 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| Thymalfasin for Injection | CYHB2601718 | Supplement | 2026/09/10 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600057 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600056 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600055 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600054 | New drug | 2026/04/22 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600053 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600052 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600051 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | CXHS2600050 | New drug | 2026/04/09 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| Clindamycin Palmitate Hydrochloride Granules | CYHS2501776 | Generic | 2025/05/15 | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
20 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Vonoprazan Fumarate Tablets | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20265532 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20265533 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Epalrestat Tablets | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20263399 | 2026/02/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atosiban Acetate Injection | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20256143 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atosiban Acetate Injection | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20256144 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Agomelatine Tablets | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20255026 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cetrorelix Acetate for Injection | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20254895 | 2025/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvoxamine Maleate Tablets | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20254175 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ezetimibe and Atorvastatin Calcium Tablets(II) | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20253267 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 依折麦布阿托伐他汀钙片(I) · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20253268 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方匹可硫酸钠颗粒 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20249016 | 2024/10/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20244919 | 2024/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 磷酸奥司他韦颗粒 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20243826 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil and Amlodipine Besylate Tablets | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20233968 | 2023/07/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bivalirudin for Injection | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20233652 | 2023/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20223349 | 2022/05/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eptifibatide Injection | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20213582 | 2021/07/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thymalfasin for Injection | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20193335 | 2021/01/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alogliptin Benzoate Tablets | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20203502 | 2020/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glucosamine Sulfate Capsules | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | 国药准字H20265649 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
23 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 司美格鲁肽 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20250001233 | I | 2026/03/16 | CDE ↗ |
| 依折麦布 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20260000100 | I | 2026/02/11 | CDE ↗ |
| 玛仕度肽 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20250001166 | I | 2025/11/05 | CDE ↗ |
| 艾普拉唑 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20250000996 | I | 2025/09/19 | CDE ↗ |
| 罗沙司他 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20250000239 | A | 2026/10/14 | CDE ↗ |
| 联苯苄唑 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20240000565 | A | 2026/06/02 | CDE ↗ |
| 醋酸阿托西班 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20240000039 | A | 2025/11/21 | CDE ↗ |
| 舒林酸 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20230001372 | A | 2026/07/09 | CDE ↗ |
| 醋酸去氨加压素 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20220001250 | A | 2025/07/25 | CDE ↗ |
| 利拉鲁肽 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20220000633 | I | 2023/02/07 | CDE ↗ |
| 司美格鲁肽 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20220001086 | I | 2023/01/10 | CDE ↗ |
| 依帕司他 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20220001175 | A | 2026/07/18 | CDE ↗ |
| 匹可硫酸钠 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20220000698 | A | 2024/10/17 | CDE ↗ |
| 醋酸西曲瑞克 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20220000567 | A | 2024/06/06 | CDE ↗ |
| 阿托伐他汀钙 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20210001031 | A | 2025/08/10 | CDE ↗ |
| 氟维司群 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20200001489 | A | 2025/08/24 | CDE ↗ |
| 艾博韦泰 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20200001298 | A | 2023/07/12 | CDE ↗ |
| 磷酸奥司他韦 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20200000736 | A | 2026/10/11 | CDE ↗ |
| 醋酸奥曲肽 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20180001746 | A | 2025/08/23 | CDE ↗ |
| 比伐芦定 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20190000290 | A | 2025/08/23 | CDE ↗ |
| 依替巴肽 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20180001360 | A | 2026/04/13 | CDE ↗ |
| 苯甲酸阿格列汀 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20180000506 | A | 2025/02/19 | CDE ↗ |
| 胸腺法新 · No verified English name | Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | Y20170001373 | A | 2023/07/14 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
11 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Estradiol Valerate Tablets | CYHS2601955 | Generic | 2026/08/10 | Shandong Qidu Pharmaceutical Co., Ltd.; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 玛仕度肽注射液 · No verified English name | CYHB2601113 | Supplement | 2026/06/12 | Xin Da Biopharmaceutical (Suzhou) Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 玛仕度肽注射液 · No verified English name | CYHB2502608 | Supplement | 2025/12/30 | Xin Da Biopharmaceutical (Suzhou) Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | JTS2400160 | Not stated by source | 2024/12/10 | Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | JTS2400129 | Not stated by source | 2024/10/18 | Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | JTS2400128 | Not stated by source | 2024/10/18 | Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | JTS2400127 | Not stated by source | 2024/10/18 | Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | JTS2400126 | Not stated by source | 2024/10/18 | Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| 司美格鲁肽注射液 · No verified English name | JTS2400125 | Not stated by source | 2024/10/18 | Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| Alogliptin Benzoate Tablets | CYHB2300007 | Supplement | 2023/01/04 | Zhejiang Hua Bei Pharma Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
| Amlodipine Besylate and Atorvastatin Calcium Tablets | CYHS2200454 | Generic | 2022/03/16 | Zhejiang Zhang Dian Drug Technology Kai Fa Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.